Skip to content

The role of diverting stoma in low anterior resection for rectal cancer -A prospective multicenter study.

The role of diverting stoma in low anterior resection for rectal cancer -A prospective multicenter study. - Diverting stoma in low rectal cancer surgery.

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
JPRN
Registry ID
JPRN-UMIN000004017
Enrollment
1000
Registered
2010-08-09
Start date
2010-07-01
Completion date
Unknown
Last updated
2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Rectal cancer

Interventions

None listed

Sponsors

Japanese Society for Cancer of the Colon and Rectum
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: Preoperative inclusion criteria are biopsy proven adenocarcinoma of the rectum located at within 10cm above the anal verge measured with a rectoscope and/or digital examination, informed consent, ability to understand the study information, and initial operation for rectal cancer excluding local excision. Intraoperative inclusion is patients undergoing low anterior resection with mechanical anastomosis. Preoperative radiotherapy, chemotherapy, and laparoscopic surgery are at the choice of the surgeon.

Exclusion criteria

Exclusion criteria: Exclusion criteria are anastomosis with hand sewn technique, emergency operation, and no ability to understand the study information.

Design outcomes

Primary

MeasureTime frame
Primary outcome are to investigate the rate of anastomotic leak including radiological leak at discharge in low rectal cancer patients undergoing low anterior resection with or without diverting stoma, and to evaluate the need for diverting stoma in patients undergoing low anterior resection.

Secondary

MeasureTime frame
Risk factors related to anastomotic leakage

Countries

Japan

Contacts

Public ContactAkio Shiomi

Shizuoka Cancer Center Colon and Rectal Surgery

a.shiomi@scchr.jp+81-55-989-5222

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026